SRT

Strata Critical Medical, Inc. Class A Common Stock (SRTA) Q4 2024 Annual Earnings

SRTA·Reported March 13, 2025·Before market open

Strata Critical Medical, Inc. Class A Common Stock reported Q4 2024 revenue of $54.4M, beat analyst consensus of $51.0M by $3.4M. Diluted EPS came in at $-0.12.

Revenue
$54.4Mbeat by $3.4M
Consensus: $51.0M
Diluted EPS
$-0.12met estimate
Consensus: $-0.12
SEC

SEC Filings

Earnings release8-K not filed yet
Annual report10-K · 0001779128-25-000010

Financial Snapshot

Trailing eight quarters through Q4 2024

View all metrics

Revenue

View metric

Net Income

View metric

Operating Cash Flow

View metric

EPS (Diluted)

View metric

Q4 2024 Earnings FAQ

Common questions about Strata Critical Medical, Inc. Class A Common Stock's Q4 2024 earnings report.

Strata Critical Medical, Inc. Class A Common Stock (SRTA) reported Q4 2024 earnings on March 13, 2025 before market open.

Strata Critical Medical, Inc. Class A Common Stock reported revenue of $54.4M and diluted EPS of $-0.12 for Q4 2024.

Revenue beat the consensus estimate of $51.0M by $3.4M. EPS beat the consensus estimate of $-0.12 by $0.00.

You can read the 10-K periodic report (0001779128-25-000010) directly on SEC EDGAR. The filing index links above go to sec.gov.